Search research articles
Contact Us
Filters
Showing results (11-20 of 18) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 18 results.
Revue Neurologique
|
January 1, 1991
[Genetics of neurofibromatosis: recent progress and prospects]
M Maillet-Vioud, S Narod, D Assouline, et al.
Cancer
|
September 26, 1997
Prognosis of patients with advanced Hodgkin's disease: evaluation of four prognostic models using 344 patients included in the Group d'Etudes des Lymphomes de l'Adulte Study
C Fermé, Y Bastion, P Brice, et al.
Leukemia & Lymphoma
|
December 29, 1999
Continuous-infusion carboplatin in combination with idarubicin or mitoxantrone for high-risk acute myeloid leukemia: a randomised phase II study
A Belhabri, X Thomas, J Troncy, et al.
British Journal of Cancer
|
May 5, 2001
Combined paclitaxel and gemcitabine as first-line treatment in metastatic non-small cell lung cancer: a multicentre phase II study
J Y Douillard, D Lerouge, A Monnier, et al.
The New England Journal of Medicine
|
January 4, 1990
Leukemia following Hodgkin's disease
J M Kaldor, N E Day, E A Clarke, et al.
Transplantation
|
January 15, 1996
Hodgkin's disease after transplantation
J L Garnier, Y Lebranchu, J Dantal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 21, 1998
Meta-analysis of chemotherapy versus combined modality treatment trials in Hodgkin's disease. International Database on Hodgkin's Disease Overview Study Group
M Loeffler, O Brosteanu, D Hasenclever, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 21, 2011
Combination of rituximab, bortezomib, doxorubicin, dexamethasone and chlorambucil (RiPAD+C) as first-line therapy for elderly mantle cell lymphoma patients: results of a phase II trial from the GOELAMS
R Houot, S Le Gouill, M Ojeda Uribe, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 18) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 18 results.
Revue Neurologique
|
January 1, 1991
[Genetics of neurofibromatosis: recent progress and prospects]
M Maillet-Vioud, S Narod, D Assouline, et al.
Cancer
|
September 26, 1997
Prognosis of patients with advanced Hodgkin's disease: evaluation of four prognostic models using 344 patients included in the Group d'Etudes des Lymphomes de l'Adulte Study
C Fermé, Y Bastion, P Brice, et al.
Leukemia & Lymphoma
|
December 29, 1999
Continuous-infusion carboplatin in combination with idarubicin or mitoxantrone for high-risk acute myeloid leukemia: a randomised phase II study
A Belhabri, X Thomas, J Troncy, et al.
British Journal of Cancer
|
May 5, 2001
Combined paclitaxel and gemcitabine as first-line treatment in metastatic non-small cell lung cancer: a multicentre phase II study
J Y Douillard, D Lerouge, A Monnier, et al.
The New England Journal of Medicine
|
January 4, 1990
Leukemia following Hodgkin's disease
J M Kaldor, N E Day, E A Clarke, et al.
Transplantation
|
January 15, 1996
Hodgkin's disease after transplantation
J L Garnier, Y Lebranchu, J Dantal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 21, 1998
Meta-analysis of chemotherapy versus combined modality treatment trials in Hodgkin's disease. International Database on Hodgkin's Disease Overview Study Group
M Loeffler, O Brosteanu, D Hasenclever, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 21, 2011
Combination of rituximab, bortezomib, doxorubicin, dexamethasone and chlorambucil (RiPAD+C) as first-line therapy for elderly mantle cell lymphoma patients: results of a phase II trial from the GOELAMS
R Houot, S Le Gouill, M Ojeda Uribe, et al.
Page
of 2